(Q57711656)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161509%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161509%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161509%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Lisa Langsetmo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161509%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Claudie Berger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161509%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

L M Lix

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161509%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

D Goltzman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161509%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

D A Hanley

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161509%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

J D Adachi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161509%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

H Johansson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161509%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A Oden

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161509%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

E McCloskey

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161509%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

J A Kanis

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161509%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

16 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161509%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

number of pages

11

1 reference

Osteoporosis International

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161509%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161509%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161509%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

817-827

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161509%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00198-010-1464-2

18 January 2020

exact match

0 references

cites work

Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos).

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Population-based Canadian hip fracture rates with international comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Economic implications of hip fracture: health service use, institutional care and cost in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Lengthy hospitalization associated with vertebral fractures despite control for comorbid conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Mortality after all major types of osteoporotic fracture in men and women: an observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

The Influence of Osteoporotic Fractures on Health-Related Quality of Life in Community-Dwelling Men and Women across Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Updated data on proximal femur bone mineral levels of US adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

A reference standard for the description of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Low bone mineral density and fracture burden in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

FRAX and its applications to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

International variations in hip fracture probabilities: implications for risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

FRAX and the assessment of fracture probability in men and women from the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

A revised clinician's guide to the prevention and treatment of osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

The potential impact of new National Osteoporosis Foundation guidance on treatment patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

The effects of a FRAX revision for the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Updated fracture incidence rates for the US version of FRAX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Establishing a Regional Bone Density Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

A population-based study of osteoporosis testing and treatment following introduction of a new bone densitometry service

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Construction and validation of a population-based bone densitometry database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

The importance of spectrum bias on bone density monitoring in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

BMD, clinical risk factors and their combination for hip fracture prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Comparative Effects of Densitometric and Absolute Fracture Risk Classification Systems on Projected Intervention Rates in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Changes to osteoporosis prevalence according to method of risk assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Zoledronic acid and clinical fractures and mortality after hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Ten-year fracture probability identifies women who will benefit from clodronate therapy--additional results from a double-blind, placebo-controlled randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Cost-effective osteoporosis treatment thresholds: the United States perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. National Osteoporosis Foundation Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1464-2

Excess mortality after hospitalisation for vertebral fracture

21 January 2018

1 reference

12 December 2020

The components of excess mortality after hip fracture

1 reference

12 December 2020

Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos

1 reference

12 December 2020

Mortality after osteoporotic fractures

1 reference

12 December 2020

Revisiting the Manitoba Centre for Health Policy and Evaluation and its population-based health information system

1 reference

12 December 2020

The diagnosis of osteoporosis

1 reference

12 December 2020

Independent clinical validation of a Canadian FRAX tool: Fracture prediction and model calibration

1 reference

12 December 2020

Time since prior fracture is a risk modifier for 10-year osteoporotic fractures

1 reference

12 December 2020

Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations

1 reference

12 December 2020

Recommendations for bone mineral density reporting in Canada

1 reference

12 December 2020

Universal standardization for dual X-ray absorptiometry: patient and phantom cross-calibration results

1 reference

12 December 2020

10.1007/S00198-010-1464-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21161509%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference